Td Private Client Wealth LLC Viking Therapeutics, Inc. Transaction History
Td Private Client Wealth LLC
- $3.58 Trillion
- Q4 2024
A detailed history of Td Private Client Wealth LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 12 shares of VKTX stock, worth $307. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12Holding current value
$307% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VKTX
# of Institutions
468Shares Held
65.9MCall Options Held
5.8MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$261 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$155 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$126 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$66.5 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$55.3 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $1.97B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...